November, 2022

article thumbnail

AI tailors artificial DNA for future drug development

The Pharma Data

AI tailors artificial DNA for future drug development. With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production.

DNA 83
article thumbnail

Long-COVID personalized medicine enters Phase 2 trial

BioPharma Reporter

GeNeuro has recruited the first patients in a Phase 2 trial evaluating temelimab against long-COVID: assessing the efficacy of the treatment for improving cognitive impairment and fatigue. Bio Developments

Medicine 114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy

Fierce Pharma

Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy. ntaylor. Mon, 11/28/2022 - 10:11

Trials 97
article thumbnail

FDA approves first gene therapy for hemophilia B

Bio Pharma Dive

The treatment, which is for the less common “B” form of the bleeding disorder, will be sold in the U.S. by maker CSL for $3.5 million

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

AI will continue to attract investment in near future in the healthcare industry

Pharmaceutical Technology

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.

Big Data 285
article thumbnail

Role of data in shaping the future of Healthcare AI

Pharma Mirror

As AI technology advances, it is quickly finding its way into the world of healthcare. The rise of machine learning and chatbots in healthcare is moving away from the traditionally doctor-centric model and towards a more patient-centric and automated process built on trust and data.

Doctors 130

More Trending

article thumbnail

What Matters Most: The Trends That Will Shape Pharma Marketing in 2023

Eversana Intouch

Download the White Paper. Big concepts. Big platforms. Big words. Big decisions. That’s where we all want to play. It’s easy to toss big words around, though: to be provocative, to hype, to make unsupported claims. It’s far more difficult to be precise, accurate, meaningful. To have impact.

article thumbnail

Digital cognitive behaviour therapies recommended by NICE across the NHS

Pharma Times

Treatment will assist young people and children with symptoms of mild-to-moderate anxiety

118
118
article thumbnail

What to make of Eisai and Biogen’s latest Alzheimer’s drug data

Bio Pharma Dive

At a medical conference, the companies detailed clinical trial results that could help support approval of their drug, lecanemab. However, some doctors aren’t yet convinced the medicine’s risks are worth its potential benefits

Doctors 282
article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus.

Antibody 284
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market 

Pharma Mirror

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Packaging 130
article thumbnail

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022

The Pharma Data

AMGEN TO WEBCAST INVESTOR CALL AT WCIRDC 2022. Amgen (NASDAQ: AMGN) will host a webcast call for the investment community in conjunction with the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) at 8:00 a.m. ET on Monday, Dec. 5, 2022. David M. Reese, M.D.,

Insulin 83
article thumbnail

Brain cancer vaccine succeeds at prolonging survival in Phase 3 trial

BioPharma Reporter

A Phase 3 trial for Northwest Biotherapeuticsâs DCVax-L vaccine extended survival in patients with gliobastoma for many months, or in some cases, years: according to new data. Bio Developments

Trials 114
article thumbnail

Medicines for Malaria Venture and Novartis move to phase 3 trial

Pharma Times

Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments

Medicine 114
article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Narcan developer to be acquired by Indivior

Bio Pharma Dive

The deal, which could carry a total value of roughly $145 million, is in large part focused on a nasal formulation of the opioid overdose drug nalmefene

article thumbnail

Cyagen and Neurophth partner to develop gene therapy vectors

Pharmaceutical Technology

Cyagen and Neurophth Therapeutics have entered a strategic partnership to jointly develop next-generation AAV gene therapy vectors for specific kinds of genetic ophthalmic ailments.

article thumbnail

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments

Fierce Pharma

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. Thu, 11/10/2022 - 09:02

Antibody 114
article thumbnail

Quadripartite welcomes new political commitments in the fight against antimicrobial resistance

The Pharma Data

Quadripartite welcomes new political commitments in the fight against antimicrobial resistance.

article thumbnail

Could digital therapeutics provide a solution against opioid abuse?

Pharma Phorum

Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition.

article thumbnail

New device launched for diagnosing prostate cancer

Pharma Times

CamPROBE may save vital time and money while reducing the risk of infection

114
114
article thumbnail

Building a biotech in a downturn: 3 lessons from VCs and startup CEOs

Bio Pharma Dive

In a panel discussion hosted by BioPharma Dive, venture capitalists and CEOs discussed how startups can navigate a challenging market as well as possible ripple effects from the new U.S. drug pricing law

Marketing 285
article thumbnail

NHS expedites rollout of Bayer’s darolutamide for prostate cancer

Pharmaceutical Technology

The National Health Service (NHS) in England, UK, has expedited the rollout of Bayer ’s new life-extending drug, darolutamide, to treat the most advanced kinds of prostate cancer that have spread to other body parts.

Branding 241
article thumbnail

Moderna can't hide behind the government in patent infringement suit, judge rules

Fierce Pharma

Moderna can't hide behind the government in patent infringement suit, judge rules. zbecker. Thu, 11/03/2022 - 15:47

114
114
article thumbnail

WHO recommends a new name for monkeypox disease

The Pharma Data

WHO recommends a new name for monkeypox disease. Following a series of consultations with global experts, WHO will begin using a new preferred term “mpox” as a synonym for monkeypox. Both names will be used simultaneously for one year while “monkeypox” is phased out.

82
article thumbnail

Advanced therapies and the high-profile pricing dilemma

Pharma Phorum

The advancements made in drug development over the last decade have seen the arrival of a number of treatments that offer one-time cures and more effective therapies for conditions in smaller patient populations.

article thumbnail

Touchlight receives funding to develeop DNA vaccine platform

Pharma Times

Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA

DNA 111
article thumbnail

Centerview grows role as go-to adviser for biopharma dealmaking

Bio Pharma Dive

Over the past several years, the investment firm has served as a financial adviser on biopharma acquisitions worth more than $200 billion in total, with the latest announced Monday

281
281
article thumbnail

AstraZeneca enters $320m deal to acquire Neogene

Pharmaceutical Technology

AstraZeneca has signed an agreement for the acquisition of all outstanding equity of clinical-stage biotechnology firm Neogene Therapeutics in a deal totalling up to $320m.

article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

The FDA Law Blog

By Sophia R. Gaulkin — We previously blogged about Pfizer’s copay assistance lawsuit, which sought to challenge HHS’s interpretation of the Federal health care program anti-kickback statute (AKS) and position that the company’s proposed copay assistance program would violate the AKS.

article thumbnail

Quadripartite launches a new platform to attack antimicrobial resistance trouble to mortal and beast health and ecosystems

The Pharma Data

Quadripartite launches a new platform to attack antimicrobial resistance trouble to mortal and beast health and ecosystems.

article thumbnail

Data privacy concerns don’t hinder digital health app usage

Pharma Phorum

A new survey conducted by juli, an AI-powered chronic condition platform, has revealed that the value placed on digital privacy differs widely among US users.

Marketing 103
article thumbnail

Study brings personalised immunotherapy prescriptions closer

Pharma Times

Research showed that prescribing based solely on levels of proteins present is unlikely to be suitable

Protein 112
article thumbnail

Biotechs reveal layoffs, research revamps in third quarter earnings

Bio Pharma Dive

Tricida, Harpoon, Freeline and three other small drug developers have this week announced plans to cut staff or to reprioritize their drug development

Drugs 275
article thumbnail

Ozempic compensating for Wegovy’s supply shortage due to high demand

Pharmaceutical Technology

In recent months, Wegovy (semaglutide), indicated for obesity, has been subjected to widespread supply shortages due to high demand, in addition to manufacturer production problems, with Novo Nordisk intending to relaunch Wegovy by the end of 2022.

Sales 229